Aerucin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Aerucin, covering 2015-12-30 to 2022-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia [Phase 2]